MARKET

EUCRU

EUCRU

Eucrates Biomedical Acquisition Corp.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.25
-0.13
-1.23%
Closed 16:00 03/05 EST
OPEN
10.44
PREV CLOSE
10.38
HIGH
10.44
LOW
10.25
VOLUME
8.36K
TURNOVER
--
52 WEEK HIGH
11.17
52 WEEK LOW
9.91
MARKET CAP
102.50M
P/E (TTM)
36.00
1D
5D
1M
3M
1Y
5Y
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
, /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination ...
PR Newswire - PRF · 12/14/2020 22:22
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
, /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination ...
PR Newswire - PRF · 12/14/2020 22:22
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
PR Newswire · 12/14/2020 22:22
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more bu...
PR Newswire · 12/14/2020 22:22
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more bu...
PR Newswire · 12/14/2020 22:22
Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering
PR Newswire · 10/27/2020 21:17
Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering
PR Newswire · 10/27/2020 21:17
Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering
, /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the closing of its initial public offering of 10,000,000 units at an initial public offering price of per unit. The units are listed on The Nasdaq Capital Market ("Nasdaq") and commenced trading under the ticker symbol "EUCRU" beginning on . Each unit consists of one ordinary share of the Company and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one ordinary share of the Company at an exercise price of per share. Once the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on Nasdaq under the symbols "EUCR" and "EUCRW," respectively.
PR Newswire - PRF · 10/27/2020 20:17
More
No Data
Learn about the latest financial forecast of EUCRU. Analyze the recent business situations of Eucrates Biomedical Acquisition Corp. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
More
About EUCRU
Eucrates Biomedical Acquisition Corp. is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company intends to focus on businesses focusing on the biomedical or healthcare-related industries. The Company is not engaged in any business operations and has generated any revenue.

Webull offers kinds of Eucrates Biomedical Acquisition Corp. stock information, including NASDAQ:EUCRU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EUCRU stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EUCRU stock methods without spending real money on the virtual paper trading platform.